Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak and Dagger Technologies at the Society for Immunotherapy of Cancer Annual Meeting
03.11.2023 - Cloak and Dagger Technologies Show Potential to Reduce Dependence on Standard Lymphodepletion and Enhance Performance of AlloCAR T CellsData from Preclinical Study of Cloak Technology Highlights Ability to Engineer Allogeneic Cells to Evade ... Seite 1
San Diego United States Zachary Roberts Dagger Technology Research Development Society For Immunotherapy Of Cancer
Source: wallstreet-online.de